US Stock MarketDetailed Quotes
ANEB Anebulo Pharmaceuticals
- 2.704
- -0.091-3.25%
Close Apr 26 16:00 ET
70.11MMarket Cap-6594P/E (TTM)
2.704High2.704Low387Volume2.704Open2.794Pre Close1.05KTurnover0.01%Turnover RatioLossP/E (Static)25.93MShares4.05052wk High10.81P/B10.55MFloat Cap1.62052wk Low--Dividend TTM3.90MShs Float9.330Historical High--Div YieldTTM0.00%Amplitude1.620Historical Low2.710Avg Price1Lot Size
Anebulo Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 30.49%-1.81M | -34.07%-2.73M | -78.09%-9.68M | -42.52%-2.85M | -49.91%-2.19M | -117.68%-2.61M | -161.46%-2.03M | -11.62%-5.44M | 42.83%-2M | -76.29%-1.46M |
| Net income from continuing operations | 28.99%-2.72M | 5.02%-2.48M | -71.89%-11.73M | -7.44%-2.5M | -49.11%-2.8M | -256.66%-3.83M | -68.14%-2.61M | 77.44%-6.83M | 92.02%-2.32M | -237.60%-1.88M |
| Change In working capital | -34.21%652.56K | -224.80%-456.8K | 28.28%1.16M | -697.96%-577.23K | 32.35%383.79K | 550.78%991.91K | -50.63%366.01K | 162.81%907.78K | 108.56%96.53K | 192.82%289.97K |
| -Change in prepaid assets | 417.10%355.57K | -124.36%-104.56K | -4.50%608.21K | 53.08%-154.95K | 4.31%265.11K | -79.64%68.76K | 14.40%429.29K | 138.19%636.89K | 69.32%-330.22K | 145.16%254.14K |
| -Change in payables and accrued expense | -67.83%297K | -456.65%-352.24K | 105.34%556.27K | -198.95%-422.28K | 231.21%118.68K | 265.51%923.15K | -117.29%-63.28K | 23.67%270.9K | 928.12%426.75K | -75.91%35.83K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 30.49%-1.81M | -34.07%-2.73M | -78.09%-9.68M | -42.52%-2.85M | -49.91%-2.19M | -117.68%-2.61M | -161.46%-2.03M | -11.62%-5.44M | 42.83%-2M | -76.29%-1.46M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 74.95%-62.35K | 0 | 6.38M | -68.16K | 0 | -248.93K | 6.7M | 0 | 0 | 0 |
| Net common stock issuance | --0 | --0 | --6.65M | --0 | --0 | --0 | --6.65M | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --0 | --0 | --52.4K | --0 | --0 | --0 | --52.4K | --0 | --0 | --0 |
| Net other financing activities | ---- | ---- | ---317.08K | ---68.16K | --0 | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 74.95%-62.35K | --0 | --6.38M | ---68.16K | --0 | ---248.93K | --6.7M | --0 | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -55.65%8.52M | -22.69%11.25M | -27.21%14.55M | -14.40%14.16M | -9.18%16.36M | 0.03%19.21M | -27.21%14.55M | 560.69%19.99M | 400.37%16.55M | 626.17%18.01M |
| Current changes in cash | 34.37%-1.88M | -158.45%-2.73M | 39.29%-3.3M | -45.92%-2.92M | -49.91%-2.19M | -138.44%-2.86M | 699.72%4.67M | -132.06%-5.44M | -111.99%-2M | -276.68%-1.46M |
| End cash Position | -59.37%6.64M | -55.65%8.52M | -22.69%11.25M | -22.69%11.25M | -14.40%14.16M | -9.18%16.36M | 0.03%19.21M | -27.21%14.55M | -27.21%14.55M | 400.37%16.55M |
| Free cash flow | 30.49%-1.81M | -34.07%-2.73M | -78.09%-9.68M | -42.52%-2.85M | -49.91%-2.19M | -117.68%-2.61M | -161.46%-2.03M | -11.62%-5.44M | 42.83%-2M | -76.29%-1.46M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg